Literature DB >> 16299687

Risk factors and underlying cardiovascular diseases in incident ESRD patients.

Attilio Di Benedetto1, Daniele Marcelli, Antonello D'Andrea, Gennaro Cice, Salvatore D'Isa, Fabio Cappabianca, Giulia Pacchiano, Roberta D'Amato, Anna Rita Oggero, Domenico Bonanno, Ornella Pergamo, Raffaele Calabrò.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in dialysis patients. The aim of this study was to evaluate the prevalence of cardiovascular risk factors and of CVD on admission to hemodialysis.
METHODS: Data were collected in 31 Italian clinics belonging to a clinic network using a prospective database (EuCliD), the main purpose of which is the support of quality assurance. Six hundred and thirty-six patients, mean age 63.9+/-15.4 years, admitted between January 1, 2000 and September 30, 2003, were separated into two groups on the basis of presence of CVD and observed for a median follow-up period of 16 months.
RESULTS: In the CVD group, patients were significantly older and the percentage of diabetics and smokers was significantly greater than in the CVD-free group. There were no significant differences between the groups in term of uremia-related risk factors. According to logistic regression analysis evaluating the impact of traditional and nontraditional cardiovascular risk factors, only smoking habit (OR 1.87, 95% CI 1.25-2.79) and diabetes (OR 1.87, 95% CI 1.19-2.95) were associated with a higher relative risk for the presence of CVD at baseline. At the time of admission, CVD was present in 27% of patients. The following de novo development of CVD was observed: hypertensive disease (0.28 new cases/100 pt-years), ischemic heart disease (0.71 new cases/100 pt-years), other forms of heart disease (1.57 new cases/100 pt-years), disease of arteries, arterioles, etc. (1.85 new cases/100 pt-years) and cerebrovascular disease (0.71 new cases/100 pt-years). The rate of developing de novo CVD events was 3.70 per 100 patient-years.
CONCLUSIONS: The prevalence of cardiovascular risk factors is already high at admission to dialysis. Despite the care provided to dialysis patients, a significant proportion of patients develop de novo CVD.

Entities:  

Mesh:

Year:  2005        PMID: 16299687

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  9 in total

1.  Outcomes after the long interdialytic break: implications for the dialytic prescription.

Authors:  Jennifer E Flythe; Eduardo Lacson
Journal:  Semin Dial       Date:  2012 Jan-Feb       Impact factor: 3.455

2.  Coronary Angiography Profile at the Time of Hemodialysis Initiation in End-Stage Renal Disease Population: A Retrospective Analysis.

Authors:  M Surendra; S Raju; K K Mukku; C H Ved Prakash; N Raju
Journal:  Indian J Nephrol       Date:  2018 Sep-Oct

3.  Sensitivity and specificity of death certificates for diabetes: as good as it gets?

Authors:  W Susan Cheng; Deborah L Wingard; Donna Kritz-Silverstein; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-10-24       Impact factor: 19.112

4.  Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification.

Authors:  Cai-Mei Zheng; Kuo-Cheng Lu; Chia-Chao Wu; Yung-Ho Hsu; Yuh-Feng Lin
Journal:  Int J Nephrol       Date:  2011-05-25

5.  Prevalence of cardiovascular risk factors in hemodialysis patients - The CORDIAL study.

Authors:  Jayme Eduardo Burmeister; Camila Borges Mosmann; Veridiana Borges Costa; Ramiro Tubino Saraiva; Renata Rech Grandi; Juliano Peixoto Bastos; Luiz Felipe Gonçalves; Guido Aranha Rosito
Journal:  Arq Bras Cardiol       Date:  2014-04-17       Impact factor: 2.000

6.  Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease.

Authors:  Cai-Mei Zheng; Yung-Ho Hsu; Chia-Chao Wu; Chien-Lin Lu; Wen-Chih Liu; Jing-Quan Zheng; Yuh-Feng Lin; Hui-Wen Chiu; Tian-Jong Chang; Jia-Fwu Shyu; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

Review 7.  Management of acute intradialytic cardiovascular complications: Updated overview (Review).

Authors:  Delia Timofte; Maria-Daniela Tanasescu; Daniela Gabriela Balan; Adrian Tulin; Ovidiu Stiru; Ileana Adela Vacaroiu; Andrada Mihai; Cristian Constantin Popa; Cristina-Ileana Cosconel; Mihaly Enyedi; Daniela Miricescu; Raluca Ioana Papacocea; Dorin Ionescu
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

8.  Ensuring hemodialysis adequacy by dialysis dose monitoring with UV spectroscopy analysis of spent dialyzate.

Authors:  Li Zhang; Wenhu Liu; Chuanming Hao; Yani He; Ye Tao; Shiren Sun; Marten Jakob; Daniele Marcelli; Claudia Barth; Xiangmei Chen
Journal:  Int J Artif Organs       Date:  2021-11-23       Impact factor: 1.595

9.  Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study.

Authors:  Rafael Pérez-García; Alejandro Martín-Malo; Joan Fort; Xavier Cuevas; Fina Lladós; Javier Lozano; Fernando García
Journal:  Nephrol Dial Transplant       Date:  2008-11-21       Impact factor: 5.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.